These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. Eliminating out-of-pocket drug costs may improve outcomes after myocardial infarction--but at what cost to Medicare? Moran A; Goldman L Nat Clin Pract Cardiovasc Med; 2008 Oct; 5(10):606-7. PubMed ID: 18695697 [TBL] [Abstract][Full Text] [Related]
35. The management of patients who have suffered an acute myocardial infarction in a tertiary care centre. Haddad H; Searles G; Gillis A Can J Cardiol; 2001 Feb; 17(2):179-83. PubMed ID: 11223488 [TBL] [Abstract][Full Text] [Related]
36. Secondary prevention following coronary artery bypass grafting has improved but remains sub-optimal: the need for targeted follow-up. Turley AJ; Roberts AP; Morley R; Thornley AR; Owens WA; de Belder MA Interact Cardiovasc Thorac Surg; 2008 Apr; 7(2):231-4. PubMed ID: 18234766 [TBL] [Abstract][Full Text] [Related]
37. Decade-long trends (1986 to 1997) in the medical treatment of patients with acute myocardial infarction: A community-wide perspective. Spencer F; Scleparis G; Goldberg RJ; Yarzebski J; Lessard D; Gore JM Am Heart J; 2001 Oct; 142(4):594-603. PubMed ID: 11579348 [TBL] [Abstract][Full Text] [Related]
38. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. ; ; ; Smith SC; Allen J; Blair SN; Bonow RO; Brass LM; Fonarow GC; Grundy SM; Hiratzka L; Jones D; Krumholz HM; Mosca L; Pearson T; Pfeffer MA; Taubert KA J Am Coll Cardiol; 2006 May; 47(10):2130-9. PubMed ID: 16697342 [No Abstract] [Full Text] [Related]
39. [Secondary prevention in patients before and after percutaneous transluminal coronary angioplasty: 5-year follow-up]. Muntwyler J; Maschio Andrist M; Amann FW Schweiz Med Wochenschr; 1997 Apr; 127(14):573-8. PubMed ID: 9198883 [TBL] [Abstract][Full Text] [Related]